Thread by @france_soir

The authors of the recovery clinical trial (Peter Horby and Martin Landray) attempt to cover up a despicable fault in the hydroxychloroquine arm. Hence the Recovery study cannot be considered serious.
#MediaCollaboratif
francesoir.fr/societe-sante/…

Results that are hiding reality, errors in the documents, the author of the appendix of the Recovery study is Dr Hayden close to Gilead defending Remdesivir EMA approved without evidence of therapeutic benefit & harmful side effects
francesoir.fr/societe-sante/…

The media are no longer content to give a voice to one side or the other by commenting, in a quest for impartiality, but are setting themselves up as true referees of what is or is not scientific and medical truth.
#MediaCollaboratif
francesoir.fr/societe-sante/…

"Almost certainly, the dose levels administered to inpatients in the Recovery trial certainly exacerbated the deteriorated lung condition of a number of patients, which a thorough and systematic review of medical records would reveal.
#MediaCollaboratif
francesoir.fr/societe-sante/…

As in a bad movie, Gilead will have pushed remdesivir, authorized by Europe without the slightest toxicity study, but it will have gone to the extent to disqualify its effective, inexpensive, innocuous competitor, hydroxychloroquine.
#MediaCollaboratif
francesoir.fr/societe-sante/…

This battle with unequal weapons does not serve the interest of public health but benefits the mastodons of the pharmaceutical industry, prepared to anything. The marketing techniques already used by Gilead are repeating themselves.
#MediaCollaboratif
francesoir.fr/societe-sante/…

The story of recovery is not over and we would not be surprised to see a mixture of dexamethasone and remdesivir point its nose shortly as a potential combination of drugs.
#MediaCollaboratif
francesoir.fr/societe-sante/…